Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CDC orders rules relaxed for home delivery pharmacy medication during the Coronavirus Pandemic

With adults 60 years and older most at risk during the pandemic, and 85% of this demographic in the U.S relying on prescriptions, maintaining access to medication is vital.(1)(2) Compared to in-store pharmaceutical visits, obtaining medication from established mail order all but eliminates the risk of exposure and helps reduce the threat of prescription stockpiling panic by ensuring regularly scheduled deliveries. MC-Rx and its affiliated home delivery pharmacies are committed to meeting that demand.


News provided by

MC-Rx

Mar 24, 2020, 08:00 ET

Share this article

Share toX

Share this article

Share toX


GAINESVILLE, Ga., March 24, 2020 /PRNewswire-PRWeb/ -- Using home delivery pharmacies to obtain prescription medications is an immediate step those who are most at risk can take to protect themselves from the COVID-19 virus, according to MC-Rx, a national Pharmacy Benefit Manager (PBM). MC-Rx announces that, effective immediately, it has enhanced several aspects of its services to the company's clients and their members to ensure medication availability. These protocols aim to adhere to current social-distancing procedures and quarantine actions while reducing the risks of both medication inaccessibility and prescription hoarding.
Details of the MC-Rx announcement include:

  • MC-Rx will support clients who are seeking to enact emergency procedures for prescriptions by allowing early refills of maintenance medications or other changes in plan design rules.
  • The MC-Rx affiliated Pharmacy Support Center will remain available 24/7 and can assist in finding available medications should any shortages occur.
  • MC-Rx will make 30-day prescriptions available at the 30-day retail price with no additional shipping fees in addition to the normal 90-day supply coverage.
  • Client support staff and clinical pharmacists will remain available for phone calls and emails from 9 AM to 6 PM Eastern Time, Monday through Friday.
  • The company's wholly owned and internally managed data centers, which can be remotely administered by its IT staff, will continue to operate without interruption.

MC-Rx is here to support our clients and their employees during these difficult times. We will work even harder to maintain your confidence as well as keep you informed of any changes

Post this

"MC-Rx is here to support our clients and their employees during these difficult times. We will work even harder to maintain your confidence as well as keep you informed of any changes," pledged Steven Treff, President and COO of MCH.

The American Pharmacists Association (APA) recently called for health insurers and PBMs to implement flexibility into their operating protocols. (3) Specifically, the APA expressed concern about long in-store waits for medicine while pharmacists "address administrative barriers." APA also stated its support for the Center for Disease Control's (CDC) recent instruction to Medicare Advantage and Part D plans to, among several changes, relax the restriction on home or mail delivery options for prescription drugs.

Few PBMs can offer such extensive depth in coordinating home delivery medication fulfillment, best prices, and medication compliance for its patients—with such skills vital considering the current pandemic. MC-Rx rises to this challenge with two commonly owned pharmacies that can ensure timely nationwide home delivery of critical medications. According to the CDC, just under half of the population has one or more prescriptions. (4) If all prescription holders switched to home delivery, it would support both the current federal and state mandates for social isolation.

Reports of requested increases in 30-day prescriptions to 90-days are rising. However, there is the concern that if this trend continues, it could cause medication shortages. Refills over normal patterns are recommended by the CDC only for "primarily high-risk patients, such as those with comorbidities," according to a trade source.(5) MC-Rx reminds plan sponsors and their members that they can rely on the well-established mail-order pharmacy fulfillment network already in place in the U.S.

About MC-Rx

MC-Rx is a full-service Pharmacy Benefits Manager (PBM) with corporate offices in Gainesville, Georgia and Caguas, Puerto Rico, focusing on transparency and best-in-class service, and offering clients "lowest net cost." MC-Rx's retail network includes more than 65,000 national, regional, and local pharmacies. MC-Rx was formed by combining two URAC certified world-class PBM's—ProCare PBM and MC-21. The ProCare companies were founded in 1988 with the vision of providing innovative computer software systems and services to various sectors of the healthcare industry. ProCare processed its first pharmacy claim in 1994 using proprietary, internally developed and managed systems and expanded in 1998 to full-service pharmacy benefit management through the acquisition of NextGen PBM. Today, the ProCare companies also include two affiliated mail-order and specialty pharmacies and are one of only five PBM providers that have built and own all of their component systems. MC-Rx now provides comprehensive, industry-leading service to clients in Puerto Rico and the U.S. For more information, visit http://www.mc-rx.com.

1. Andrew, Scottie. "Worried about Coronavirus? If Your Loved One Is over 60, Read This." CNN, Cable News Network, 13 Mar. 2020, cnn.com/2020/03/12/health/what-60-older-need-to-know-coronavirus-wellness-trnd/index.html.
2. "Products - Data Briefs - Number 332 - February 2019." Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 19 Mar. 2019, cdc.gov/nchs/products/databriefs/db334.htm.
3. "APhA Urges Insurers, PBMs to Immediately Remove Barriers on Prescription Drug Refills for Coronavirus Preparedness." Home, 13 Mar. 2020, pharmacist.com/press-release/apha-urges-insurers-pbms-immediately-remove-barriers-prescription-drug-refills.
4. "Products - Data Briefs - Number 332 - February 2019." Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 19 Mar. 2019, cdc.gov/nchs/products/databriefs/db334.htm.
5. McCook, Alison. "COVID-19: Stockpiling Refills May Strain the System." IDSE, 11 Mar. 2020, idse.net/Policy--Public-Health/Article/03-20/COVID-19-Stockpiling-Refills-May-Strain-the-System/57583.

SOURCE MC-Rx

Related Links

http://www.mc-rx.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.